Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Summary

This phase II trial is studying how well sorafenib works in treating patients with stage IIIB or stage IV non-small cell lung cancer. Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It may also stop the growth of non-small cell lung cancer by blocking blood flow to the tumor.

Timeline

Start

2004-12

Primary completion

2007-05

Completion

—

Drugs

Indications